These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 35916583)

  • 1. Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes.
    Meister MT; Groot Koerkamp MJA; de Souza T; Breunis WB; Frazer-Mendelewska E; Brok M; DeMartino J; Manders F; Calandrini C; Kerstens HHD; Janse A; Dolman MEM; Eising S; Langenberg KPS; van Tuil M; Knops RRG; van Scheltinga ST; Hiemcke-Jiwa LS; Flucke U; Merks JHM; van Noesel MM; Tops BBJ; Hehir-Kwa JY; Kemmeren P; Molenaar JJ; van de Wetering M; van Boxtel R; Drost J; Holstege FCP
    EMBO Mol Med; 2022 Oct; 14(10):e16001. PubMed ID: 35916583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fusion-negative rhabdomyosarcoma 3D organoids to predict effective drug combinations: A proof-of-concept on cell death inducers.
    Savary C; Luciana L; Huchedé P; Tourbez A; Coquet C; Broustal M; Lopez Gonzalez A; Deligne C; Diot T; Naret O; Costa M; Meynard N; Barbet V; Müller K; Tonon L; Gadot N; Degletagne C; Attignon V; Léon S; Vanbelle C; Bomane A; Rochet I; Mournetas V; Oliveira L; Rinaudo P; Bergeron C; Dutour A; Cordier-Bussat M; Roch A; Brandenberg N; El Zein S; Watson S; Orbach D; Delattre O; Dijoud F; Corradini N; Picard C; Maucort-Boulch D; Le Grand M; Pasquier E; Blay JY; Castets M; Broutier L
    Cell Rep Med; 2023 Dec; 4(12):101339. PubMed ID: 38118405
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rhabdomyosarcoma xenotransplants in zebrafish embryos.
    Siebert J; Schneider M; Reuter-Schmitt D; Würtemberger J; Neubüser A; Driever W; Hettmer S; Kapp FG
    Pediatr Blood Cancer; 2023 Jan; 70(1):e30053. PubMed ID: 36317680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Spindle cell rhabdomyosarcoma in adults: a new entity in the spectrum of malignant mesenchymal tumors of soft tissues].
    Mentzel T
    Pathologe; 2010 Mar; 31(2):91-6. PubMed ID: 19997735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Orbital rhabdomyosarcomas and related tumors in childhood: relationship of morphology to prognosis--an Intergroup Rhabdomyosarcoma study.
    Kodet R; Newton WA; Hamoudi AB; Asmar L; Wharam MD; Maurer HM
    Med Pediatr Oncol; 1997 Jul; 29(1):51-60. PubMed ID: 9142207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathological classification of childhood rhabdomyosarcomas: relationship with clinical parameters and prognosis.
    Wijnaendts LC; van der Linden JC; van Unnik AJ; Delemarre JF; Voute PA; Meijer CJ
    Hum Pathol; 1994 Sep; 25(9):900-7. PubMed ID: 8088765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors.
    Maru Y; Tanaka N; Itami M; Hippo Y
    Gynecol Oncol; 2019 Jul; 154(1):189-198. PubMed ID: 31101504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathological study of 145 childhood rhabdomyosarcoma cases].
    He LJ; Wang L; Sun N; Huang CR; Zhu XD; Lang ZQ
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):225-8. PubMed ID: 15256113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rhabdomyosarcoma: From Obscurity to Clarity in Diagnosis … But With Ongoing Challenges in Management: The Farber-Landing Lecture of 2020.
    Parham DM; Giannikopoulos P
    Pediatr Dev Pathol; 2021; 24(2):87-95. PubMed ID: 33439112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Role of Immunohistochemistry in Rhabdomyosarcoma Diagnosis Using Tissue Microarray Technology and a Xenograft Model.
    Machado I; Mayordomo-Aranda E; Giner F; Llombart-Bosch A
    Fetal Pediatr Pathol; 2015; 34(5):271-81. PubMed ID: 26125949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathology of childhood and adolescent rhabdomyosarcoma].
    Leuschner I; Harms D
    Pathologe; 1999 Mar; 20(2):87-97. PubMed ID: 10320996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 and mdm-2 expression in Rhabdomyosarcoma of childhood and adolescence: clinicopathologic study by the Kiel Pediatric Tumor Registry and the German Cooperative Soft Tissue Sarcoma Study.
    Leuschner I; Langhans I; Schmitz R; Harms D; Mattke A; Treuner J;
    Pediatr Dev Pathol; 2003; 6(2):128-36. PubMed ID: 12574910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Childhood rhabdomyosarcoma with anaplastic (pleomorphic) features. A report of the Intergroup Rhabdomyosarcoma Study.
    Kodet R; Newton WA; Hamoudi AB; Asmar L; Jacobs DL; Maurer HM
    Am J Surg Pathol; 1993 May; 17(5):443-53. PubMed ID: 8470759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Developmental origins of fusion-negative rhabdomyosarcomas.
    Kikuchi K; Rubin BP; Keller C
    Curr Top Dev Biol; 2011; 96():33-56. PubMed ID: 21621066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and prognostic analysis of single-center multidisciplinary treatment for rhabdomyosarcoma in children].
    Xu N; Duan C; Jin M; Zhang DW; Su Y; Yu T; He LJ; Fu LB; Zeng Q; Wang HM; Zhang WP; Ni X; Ma XL
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):767-773. PubMed ID: 31594063
    [No Abstract]   [Full Text] [Related]  

  • 16. Uterine rhabdomyosarcoma in adults.
    Pinto A; Kahn RM; Rosenberg AE; Slomovitz B; Quick CM; Whisman MK; Huang M
    Hum Pathol; 2018 Apr; 74():122-128. PubMed ID: 29320751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma.
    Dehner CA; Armstrong AE; Yohe M; Shern JF; Hirbe AC
    Genes (Basel); 2021 Sep; 12(10):. PubMed ID: 34680895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pediatric soft tissue sarcomas.
    Loeb DM; Thornton K; Shokek O
    Surg Clin North Am; 2008 Jun; 88(3):615-27, vii. PubMed ID: 18514702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genomic analysis and preclinical xenograft model development identify potential therapeutic targets for MYOD1-mutant soft-tissue sarcoma of childhood.
    Ting MA; Reuther J; Chandramohan R; Voicu H; Gandhi I; Liu M; Cortes-Santiago N; Foster JH; Hicks J; Nuchtern J; Scollon S; Plon SE; Chintagumpala M; Rainusso N; Roy A; Parsons DW
    J Pathol; 2021 Sep; 255(1):52-61. PubMed ID: 34086347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience.
    Rekhi B; Gupta C; Chinnaswamy G; Qureshi S; Vora T; Khanna N; Laskar S
    Ann Diagn Pathol; 2018 Oct; 36():50-60. PubMed ID: 30098515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.